Effectiveness and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael McLane
Endo USA Inc., a Keenova Therapeutics Company
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Endo Clinical Trial Site #1
Scottsdale, Arizona, United States
- Endo Clinical Trial Site #2
Encinitas, California, United States
- Endo Clinical Trial Site #3
Long Beach, California, United States
- Endo Clinical Trial Site #4
Los Angeles, California, United States
- Endo Clinical Trial Site #5
Oceanside, California, United States
- Endo Clinical Trial Site #6
San Diego, California, United States
- Endo Clinical Trial Site #7
Boca Raton, Florida, United States
- Endo Clinical Trial Site #8
Largo, Florida, United States
- Endo Clinical Trial Site #9
Miami, Florida, United States
- Endo Clinical Trial Site #10
Snellville, Georgia, United States
- Endo Clinical Trial Site #11
Chicago, Illinois, United States
- Endo Clinical Trial Site #12
New Orleans, Louisiana, United States
- Endo Clinical Trial Site #13
Chestnut Hill, Massachusetts, United States
- Endo Clinical Trial Site #14
Quincy, Massachusetts, United States
- Endo Clinical Trial Site #15
Fridley, Minnesota, United States
- Endo Clinical Trial Site #16
Washington, Missouri, United States
- Endo Clinical Trial Site #17
Omaha, Nebraska, United States
- Endo Clinical Trial Site #18
Mount Kisco, New York, United States
- Endo Clinical Trial Site #19
New York, New York, United States
- Endo Clinical Trial Site #20
New York, New York, United States
- Endo Clinical Trial Site #21
New York, New York, United States
- Endo Clinical Trial Site #22
Cincinnati, Ohio, United States
- Endo Clinical Trial Site #23
Houston, Texas, United States
- Endo Clinical Trial Site #24
Pflugerville, Texas, United States
- Endo Clinical Trial Site #25
Sugar Land, Texas, United States
- Endo Clinical Trial Site #26
Charlottesville, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Feb 2018
- Primary completion
- 26 Sept 2018
- Completion
- 26 Sept 2018
- Last update posted
- 8 Oct 2020
- Registered enrollment
- 423
- Registry id
- NCT03428750
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.